Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Futures up for the start of another Santa Rally week in 2023! AXXA also up on Friday so we'll see if AXXA can muster up some more gains this week and then in the final week of 2023!
Looking forward to a strong AXXA 2024!
Green is Green! We'll see how the rest of 2023 goes!
Looks like the Santa Rally came to town today for the DOW, NAS and S&P, and a little late-day rally for AXXA too!
Futures are up for tomorrow, so looking forward to the Santa Rally continuing!
Are the audits done by the same place (Count the Penny) but a different person since they are listed as Accountant/Auditor?
I guess we'll see what update AXXA provides..... I was surprised that the photos matched and the Marriott connection to that particular Castle Hotel. I also see that the Odyssey Hotel Group operates the Schloss Lieser (https://www.odysseyhotelgroup.com/). The mystery continues!
Did a little more Castle Hotel digging and to my surprise found a Castle Hotel that has 49 rooms and has the same picture of a room that you will see on AXXA's website (see links below for the comparison). Look through the photos on the booking.com link below and compare to the AXXA link photo. There is also a direct link to the hotel.
In addition, there is a significant additional finding that this is a Marriott hotel (Autograph Collection). This tells me that AXXA either used a stock photo, or Marriott bought it from under AXXA, or AXXA is renegotiating with Marriott. Whatever the case is, some clarity is needed sooner rather than later to unravel this mystery.
https://exxegroup.com/the-castle-five-star-luxury-hotel-germany/
https://www.booking.com/hotel/de/schloss-lieser-autophraph-collection.en-us.html?aid=2016796&sid=e3a67222677a343d0b2251cbb38b13de&dist=0&group_adults=1&keep_landing=1&no_rooms=1&sb_price_type=total&type=total&activeTab=photosGallery
https://www.schlosslieser.de/hotel-eng-2/
Perhaps one of these Castle Hotels (see link).....and will be revealed in 2024. AXXA website says it has 50 rooms and from the last Q report AXXA is renegotiating the remaining balance of the deposit which is expected to take 2-3 quarters.
https://manorcastles.com/places/germany-1/
Not sure that is the luxury hotel because it has over 50 rooms. Nonetheless, I would anticipate an update early in 2024 on the status of AXXA taking majority control of the luxury "Castle" hotel in Germany and the luxury resort in Thailand.
Thanks. Seems like an update is due soon then assuming they are competent and focused!
Next week should tell us how the rest of 2023 will go and what to expect in 2024!
https://finance.yahoo.com/news/decisive-moment-arrives-4-trillion-150000837.html
My speculation is that the DOW heads toward $40,000, NAS toward $16,000, S&P toward $5,400.
What about AXXA? I speculate it will head back toward $0.10.
This is merely speculation based on the recent stock market rally and assumption that the rally continues through 2024!
S&P now predicted to hit $5400 in 2024 based on a rare signal......this is about 2 years after the last new high in January 2022.
https://finance.yahoo.com/news/extremely-rare-stock-market-signal-010830319.html
Not sure if AXXA will hit a new high in 2024, but it has also been about 2 years since the last high for AXXA in December 2021.
Mine is not a theory...it is speculation based on an upturn in the overall market which appears to be continuing in December 2023 and expected to continue into 2024. Based on that, and the fact that AXXA has had a downturn for almost 2 years (since late December 2021), I'm speculating that AXXA will upturn this month and into 2024. 2024 looks like it will be a pivotal year for an AXXA turnaround based on continued increasing revenue coupled with a share repurchase program and audit plan (including recently hiring an auditor).
Here are the 3 catalysts set to propel stocks higher in 2024....
https://finance.yahoo.com/news/3-catalysts-set-propel-stocks-000033247.html
Will AXXA join the AI craze and go bonkers in 2024?
The case for S&P 500 to hit 5,200 in 2024: One of Wall Street's biggest bulls sees the S&P 500 (^GSPC) surging more than 13% over the next year.
6 hours ago; Josh Schafer
https://finance.yahoo.com/news/wall-street-bull-gives-highest-2024-sp-forecast-yet-192122201.html
Fundstrat's head of research Tom Lee projects the benchmark index will end 2024 at 5,200 as falling inflation leads to easing financial conditions and the US economy once again skirts recession.
Lee's target is the highest among strategists tracked by Yahoo Finance, surpassing both Deutsche Bank and BMO Capital Markets' call for 5,100 for the S&P at the end of next year.
Lee had a 4,750 call on the S&P going into this year, which he described as a higher-than-consensus prediction largely because he felt inflation would fall more than others and the US economy wouldn't slip into recession. With markets now cheering soft inflation prints and signs the economy is still growing, Lee thinks a similar narrative plays out in 2024.
"2023 was a year where the [stock market] technicians got it right ... and economists got it wrong" Lee said at a 2024 outlook roundtable on Thursday. "In 2024, I think that this is actually still a residual game plan ... the technicians will get the year right and the economists are gonna get the year wrong."
I'm not saying the OTC and S&P are the same. I'm saying that the market went "bonkers" in late 2021 to include the OTC and the S&P (as well as the the NAS and DOW). Just looking for a repeat around the 2 year anniversary of that "bonkers" year!
I seen predictions ranging from $3500-5000 for 2024. We'll see what reality brings. Today's reality supports $5000!
It is a comparison between December 2021 and December 2023 for both the S&P and AXXA. They both went up in 2021 so looking for the same in December 2023, specifically on the 21st!
Santa is putting a little more GREEN in the S&P sleigh today - almost $4600!
Update: They added the meeting in January 2024 to review progress on the tasks related to the CSRP.
Exxe Group Common Share Repurchase Plan (from the Q2FY24 Report)
"On October 18, 2023 the Company announced its Board of Directors passed Board Resolutions that authorize and create an Exxe Common Share Repurchase Plan (the "CSRP"). As part of the CSRP, the Exxe Board granted authorization and instructed the Executive Management team to establish a dedicated bank account at TDBank with funds exclusively earmarked for Exxe Common Share repurchases. The Board also reviewed the entire plan to ensure that the CSRP was fully aligned with the long-term vision of improving shareholder value. The Common Share Repurchase Plan will allow the Company to initiate repurchases of Exxe Group Common Shares at the Company's discretion. Exxe Group’s Board of Directors is scheduled to meet in January 2024 to review progress on implementation by Executive Management of the establishment of the dedicated bank account and other associated and related task items."
Prepare for the S&P to go to $5000 in 2024.......
https://finance.yahoo.com/news/bank-america-says-p-500-211200353.html
Looking good!
Looks like Santa took a nap today! Let's see what Santa brings to the markets tomorrow.
Sunshine Biopharma Moves Principal Office to New York City
8:30 AM ET 12/4/23 | GlobeNewswire
Sunshine Biopharma Moves Principal Office to New York City
NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: "SBFM") (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has moved its headquarters to New York City. The Company's Head Office is now located at 1177 Avenue of the Americas, 5(th) Floor, New York, NY 10036 (Tel: 332-216-1147). The Company will maintain a satellite office at its previous headquarters in Montreal (Canada) at 6500 Trans-Canada Highway, 4(th) Floor, Pointe-Claire, Quebec, Canada, H9R 0A5 (Tel: 514-426-6161). The Company's email address (info@sunshinebiopharma.com) and URL (www.sunshinebiopharma.com) have not changed.
https://www.metro-manhattan.com/buildings/1177-avenue-of-the-americas/
Is SBFM is getting ready to expand Nora Pharma to the US?
John B Strong still seems to be working with Devvio and TS-Nano in NM. He needs to take one of them public in ADTM.
Also, finding and fixing methane gas leaks is becoming a focus recently. Hopefully this info helps relieve some of your boredom!
https://www.linkedin.com/in/johnbstrong
https://ts-nano.com/
https://www.devv.io/about
https://www.devvstream.com/
https://finance.yahoo.com/news/biden-delivers-cop28-crackdown-methane-080000203.html
I'm just looking for 08s again anytime in 2024. Maybe 01s in 2023 and up from there.
How long does it take to complete 6 years worth of audits?
I thought the same in 2021, but was proven wrong. OTC stocks went bonkers like the major indexes. Now we have gone through a major downturn for almost 2 years, but things have been turning back upward over the last couple of months and some think it will continue into 2024.
PS: Not sure if "bonkers" is the right word here, but it sounded good and looking forward to OTCs going bonkers again!
Some thoughts about Santa in today's Financial News:
"U.S. stocks rallied and the S&P registered its highest close of the year on Friday, starting December on an upbeat note as remarks from Federal Reserve Chair Jerome Powell bolstered the view that key policy rates have peaked.
All three major U.S. stock indexes advanced, with economically sensitive transports and smallcaps enjoying the most robust gains.
"Those sectors - the cyclicals - they're the most hated parts of the market year-to-date, (and they) are the parts that are leading," said Scott Ladner, chief investment officer at Horizon Investments in Charlotte, North Carolina. "On the first day of December, when everybody's looking for a Santa Claus rally, it probably carries a little bit of extra weight."
"If December starts out strong, it's going to make folks jump on board and chase this rally," Ladner added.
All three indexes notched their fifth consecutive weekly percentage gains. On Thursday, they wrapped up a banner month in which the S&P 500 and the Nasdaq registered their biggest one-month percentage gains since July 2022, and the Dow closed at its highest level since January 2022."
DOW = $36,245 NAS = $14,305 S&P = $4594 AXXA = $.0028
Where does Santa take all four by 12/21/23?
SBFM Analyst BUY rating and $3 target update:
BUY rating and price target now based primarily on Nora Pharma projected revenue growth to $100M in 2025 and achieving profitability in 2024. Below are some summary statements from the report (see link below for full report):
"We see Sunshine Biopharma as being on the verge of putting together a string of quarters with growing revenues from its generic (and OTC) drug business ramping up from $4.3 million in 2022 to an estimated $22.5 million in 2023, $44.4 million in 2024 and $100 million in 2025. We confirm our BUY recommendation for SBFM shares and our $3 Target Price."
"In our view, we recommend buying shares of SBFM based on the ramping revenues from its generic drug business. Should any one or more of Sunshine's drug pipeline be successful, we believe it could offer lottery ticket-like positive upsides which are not presently included in our target price. We think the scientific rationales behind each of the Adva-27a, PLpro and K1.1 mRNA programs are strong, but we recognize that it will be 1-5 years before initial human clinical data could be available."
https://sunshinebiopharma.com/wp-content/uploads/NOV-14-2023-AEGIS-CAPITAL-ANALYST-REPORT.pdf
If you are that confident to say Eduard is lying, what are you doing about it?
I see a lot of negative posts about Boris on this board, but he is a "Managing Director" whereas Eduard Nazmiev is signing off on the quarterly reports as both CEO and CFO. Haven't seen anything posted specifically about Eduard! Is he lying in these reports?
AXXA went from $.013 on 12/21/21 to $.13+ on 2/3/22. It has been 2 years so looking for a repeat with the overall stock market improving and lower interest rates coming in 2024.
AXXA also growing revenue and commencing a stock repurchase program during the same timeframe!
Time for another OTC Santa rally.... Last one was late 2021-early 2022.
Looks like the December Santa Claus Rally has started today! Looking to see where the DOW, NAS, S&P and AXXA land on 12/21/23!
Happy Holidays!
Looking forward to some bigger upticks on AXXA..... We're getting close to the high on 12/21/21 on the DOW ($36,800), NAS ($15,623) and S&P ($4,794) so we'll see where we land on 12/21/23 and into 2024!
Yes, and based on some market predictions I've seen it will extend through 2024! Interest rates also set to head back down in 2024.
Thanks for the quick response. Is there a timeframe to complete the audits?
Last year (2022) CCAJ announced a.......
.....RS on December 9th and the PPS tanked. This year (2023) will CCAJ announce a reversal of the RS announcement on December 9th so the PPS can go back up?
It has been almost a year and no updates on this or any acquisitions or home-building!